SELENOI — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

	Compound	Confidence	Supporting neighbours

Clinical trials — most relevant to SELENOI by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
The Effect of Q10 and Selen Supplement on Muscular Adverse Events in Statin Therapy	PHASE4	COMPLETED
Selenium Supplementation in Youths With Autoimmune Thyroiditis	PHASE4	COMPLETED
Effects of High-dose Intravenous Selenium (Selenase®) in Adult Patients Subjected to Elective All-cause Heart Surgery	PHASE3	COMPLETED
Selenium, as Sodium Selenite, in the Treatment of Septic Shock	PHASE2	COMPLETED
Non-oxidative Metabolite Profiles After Increasing Doses of Ethanol	PHASE1	COMPLETED
The Effects of a Glutathione Precursor (FT061452),on Serum and Intracellular Glutathione Levels	PHASE1	COMPLETED
Selenium Status Measured in Blood After a Higher Intake of Fish and Shellfish - a Randomized Dietary Intervention Study	PHASE1	COMPLETED
Characterization of the Pharmacokinetics of Oral Selenium Compounds in Humans Before and Following Supplementation	nan	COMPLETED
Selenoprotein P and Non-alcoholic Fatty Liver Disease	nan	COMPLETED
Selenium Supplementation of Patients With Cirrhosis	nan	COMPLETED
Selenium Levels in Patients With Abdominal Aneurysm	nan	ACTIVE_NOT_RECRUITING
Optimization of Selenoprotein P in Chinese Subjects	nan	COMPLETED
Development of Biomarker for Development of Non-Alcoholic Steatohepatitis (NASH) in Children	nan	WITHDRAWN
The Natural History of Patients With Mutations in SEPN1 (SELENON) or LAMA2	nan	COMPLETED
Selenium and Immune Function	nan	COMPLETED
A Study of the Interaction Between Tumor Susceptibility Gene Glycine N-methyltransferase (GNMT) and Lung Cancer	nan	UNKNOWN
Bipolar Disorder With Alcoholism in Han Chinese	nan	UNKNOWN
Effect of Supplementary Vitamins on Oxidant Gene Expression in the Lungs of Healthy Smokers	nan	COMPLETED
Thermogenic Silencer Regulatory Factors in Humans	nan	ACTIVE_NOT_RECRUITING
Sodium Selenite Supplementation in Patients With Head and Neck Cancer	nan	UNKNOWN
Potential Preventive Effect of Selenium on Iodine-induced Thyroid Autoimmunity During Pregnancy	nan	UNKNOWN
Effect of Sulfur Amino Acid Depletion and Acetaminophen on Plasma Glutatione	nan	COMPLETED
Genetic Variants and Regulation of Specialized Pro-resolving Mediator	nan	RECRUITING
Validation in Humans of Genes Involved in Alcohol Drinking, Stress-Induced Alcohol Drinking and Relapse	nan	COMPLETED
Selenium Supplementation in Pregnancy	nan	COMPLETED
Plant-based Diets and Body Weight and Selected Metabolic Parameters Management in Obese Patients.	nan	COMPLETED
Integrated Approaches for Identifying Molecular Targets in Alcoholic Hepatitis	nan	COMPLETED
Biomarkers for the Detection of Heavy Alcohol Use in Patients With and Without Liver Disease	nan	ACTIVE_NOT_RECRUITING
Human Selenoprotein P Concentration With Glucose Tolerance Status	nan	COMPLETED
Comparison of Thyroid Volumes in Patients With and Without Endometrioma	nan	COMPLETED

Related proteins — ESM-2 sequence neighbours (a SELENOI binder may also engage these)

Protein	Name	Similarity
Q17QM4	—	1.000	Q17QM4 →
Q5NV96	—	1.000	Q5NV96 →
Q80TA1	—	0.997	Q80TA1 →
Q66H21	—	0.994	Q66H21 →
Q8C025	—	0.994	Q8C025 →
Q8WUD6	—	0.989	Q8WUD6 →
Q1LZE6	—	0.988	Q1LZE6 →
Q7ZYQ3	—	0.987	Q7ZYQ3 →
Q8BGS7	—	0.987	Q8BGS7 →
CEPT1	Choline/ethanolaminephosphotransferase 1	0.987	landscape →
Q4KLV1	—	0.987	Q4KLV1 →
Q28H54	—	0.986	Q28H54 →
Q7ZW02	—	0.981	Q7ZW02 →
Q6AXM5	—	0.981	Q6AXM5 →
Q5ZKD1	—	0.978	Q5ZKD1 →
Q5ZHQ5	—	0.978	Q5ZHQ5 →
O82568	—	0.977	O82568 →
O82567	—	0.977	O82567 →
Q9LDU6	—	0.966	Q9LDU6 →
Q91XU8	—	0.960	Q91XU8 →
Q7ZXH1	—	0.960	Q7ZXH1 →
Q9CXR4	—	0.960	Q9CXR4 →
Q5PQQ4	—	0.959	Q5PQQ4 →
Q9LDF2	—	0.957	Q9LDF2 →
Q9Z2Z8	—	0.957	Q9Z2Z8 →
Q8K358	—	0.957	Q8K358 →
Q0D2E8	—	0.956	Q0D2E8 →
Q5R7Z3	—	0.956	Q5R7Z3 →
Q61907	—	0.956	Q61907 →
O88455	—	0.956	O88455 →